Murraya
Murraya · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Murraya is a versatile plant genus that has gained significant attention for its potential therapeutic properties. Research highlights that its leaves are particularly rich in bioactive chemical compounds, including AEGELINE, Coumarins, Crotaleschenine, and MC13. These specific constituents contribute to the plant's notable neuroprotective activities within the central nervous system. Scientific studies suggest that extracts from this plant may play a crucial role in mitigating the effects of neuroinflammation. Consequently, Murraya serves as a promising subject for developing natural interventions against various neurological conditions.
- Synonyms
- Marsana · Chalcas
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Murraya is a versatile plant known by several different names across various cultures and regions. It is frequently referred to as jasmine kit or kæmpesalat depending on the local context. Some people simply call it muraja or murraya, reflecting different linguistic variations of its identity. In Thailand, the plant is widely recognized by the common name สกุล แก้ว. These diverse names highlight the plant's widespread presence and its importance in different botanical traditions.
Sources: Catalogue of Life (COL)
Synonyms
Murraya is a botanical genus that is often identified through various historical and scientific naming conventions. Within botanical literature, you may frequently encounter the plant referred to by the synonym Chalcas. Similarly, the name Marsana is also recognized as an alternative designation for certain species within this group. These overlapping names reflect the evolving nature of taxonomic classification over time. Understanding these relationships is essential for researchers seeking to accurately identify the plant across different texts.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Murraya belongs to the vast kingdom Plantae, representing a diverse branch of the living world. Within this kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Sapindales, which connects it to a wide array of related botanical species. At a more specific level, it is a member of the family Rutaceae. Finally, this plant is defined by its placement within the genus Murraya.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Murraya |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Murraya exhibits a broad geographical range that spans across multiple continents and diverse island ecosystems. Its presence is firmly established throughout Africa and the Western Indian Ocean, including specific populations in the Comoros, Mauritius, Réunion, and the Seychelles. Beyond these tropical locales, the genus also extends into the Asia-Temperate regions. This distribution further encompasses the arid landscapes of the Arabian Peninsula and the various Gulf States. Such wide-reaching connectivity highlights the plant's ability to thrive in both oceanic and continental environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Murraya, a plant widely utilized as a culinary condiment, contains a novel coumarin compound known as MC13 that exhibits significant neuroprotective activity. Research indicates that this compound can protect neurons from inflammatory injury by suppressing the microglia-mediated response. Specifically, MC13 works by inhibiting several critical signaling pathways, including NF-κB, p38/ERK MAPKs, and Jak2-Stat1/3. By reducing the production of inflammatory mediators like TNF-α and IL-6, the compound effectively mitigates neuroinflammation. These findings suggest that derivatives from Murraya could serve as promising medicinal agents for treating neurodegenerative diseases.
Compounds
Murraya species are characterized by a diverse chemical profile that includes a wide array of bioactive secondary metabolites. These plants contain various alkaloids, such as aegeline and crotaleschenine, which have demonstrated significant potential in modulating oncogenic targets for antitumor mechanisms. Additionally, the genus is known to contain coumarins, including the novel compound MC13, which exhibits promising anti-neuroinflammatory effects. Nutrient profiling further reveals that Murraya contains saccharides such as DL-xylose, contributing to its unique metabolic characteristics. Together, these complex chemical relationships underscore the immense pharmacological potential of the genus for medicinal and industrial applications.
Conditions
Murraya contains a novel coumarin compound, MC13, that serves as a potential medicinal agent for treating neuroinflammation. This compound effectively treats lipopolysaccharide (LPS) stimulation by inhibiting various inflammatory signaling pathways and interfering with LPS-binding. Through these mechanisms, Murraya protects neurons from microglia-mediated inflammatory injury. Consequently, the plant demonstrates a significant capacity to treat inflammation-related neurodegenerative diseases. These therapeutic effects are achieved by suppressing key regulators such as NF-κB, p38/ERK MAPKs, and the Jak2-Stat1/3 signaling pathway.
Preparations
Parts used
Murraya is an economically significant crop that plays a vital role in various culinary traditions. The leaves of this plant are widely utilized as a flavorful condiment, commonly known as curry, in many cuisines. Scientific research has recently focused on the leaves to extract specialized compounds like the novel coumarin MC13. This specific component derived from the foliage has demonstrated remarkable anti-neuroinflammatory properties in laboratory studies. Such findings suggest that the medicinal potential of Murraya leaves could lead to new treatments for neurodegenerative diseases.